Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Open accessAbstract
The prevention and treatment of acute chest syndrome (ACS) is a major clinical concern in sickle cell disease (SCD).However, the mechanism underlying the pathogenesis of ACS remains elusive.We tested the hypothesis that the hemolysis byproduct hemin elicits events that induce ACS.Infusion of a low dose of hemin caused acute intravascular hemolysis and autoamplification of extracellular hemin in transgenic sickle mice, but not in sickle-trait littermates.The sickle mice developed multiple symptoms typical of ACS and succumbed rapidly.Pharmacologic inhibition of TLR4 and hemopexin replacement therapy prior to hemin infusion protected sickle mice from developing ACS.Replication of the ACS-like phenotype in nonsickle mice revealed that the mechanism of lung injury due to extracellular hemin is independent of SCD.Using genetic and bone marrow chimeric tools, we confirmed that TLR4 expressed in nonhematopoietic vascular tissues mediated this lethal type of acute lung injury.Respiratory failure was averted after the onset of ACS-like symptoms in sickle mice by treating them with recombinant hemopexin.Our results reveal a mechanism that helps to explain the pathogenesis of ACS, and we provide proof of principle for therapeutic strategies to prevent and treat this condition in mice. Results Extracellular hemin elevation causes a lethal hemolytic crisis in sickle mice.To mimic acute extracellular hemin release, transgenic Townes sickle mice (referred to herein as SS mice; see Methods) and control sickletrait (AS) and wild-type human Hb (AA) mice were infused with a relatively low dose of purified hemin (35 μmol/kg).No adverse effects were seen in the control mice, but a majority of SS mice developed labored breathing and died within 2 hours (Figure 1A).We confirmed these acute adverse effects in a second murine model of SCD (Berkeley sickle mice; see Methods) and showed that the lethality rate was dependent on the dose of hemin (Figure 1B).A previous study had shown that 40 μmol/kg hemin given i.p. did not cause any fatalities in the Berkeley sickle mouse (26).A higher dose (70 μmol/kg) given i.v. had no adverse effects in wild-type mice (17, 27); moreover, the SS mouse deaths occurred 24 hours before hepatic failure onset, due to hemin overload in septic mice (28).Thus, our results in the SS mice revealed an unusual effect of extracellular hemin that had not previously been described.Plasma hemopexin (Hx) levels decreased sharply in all animals, coincident with nearly 50% clearance of the hemin bolus within Conflict of interest: The authors have declared that no conflict of interest exists.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Animal models show that heme is directly responsible for acute lung injury in sickle cell disease mouse models.
“animal models showing that heme is directly responsible for acute lung injury in SCD mouse models (89).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [89]
High levels of hemopexin can rescue acute lung injury, while HO-1 deficiency potentiates it.
“high levels of hemopexin, the enzyme that scavenges heme, can rescue acute lung injury (89), while HO-1 deficiency potentiates it (57).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · see citing works
Animal models of acute lung injury
Matute‐Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,744 · see citing works
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 ( Tlr4 )
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525 · see citing works
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234 · see citing works
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812 · see citing works
Castro, O. L., Brambilla, D. J., Thorington, B. D., Reindorf, C. A., Scott, R., GILLETTE, P. N., Vera, J., & Levy, P. S. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 805 · see citing works
Pro-oxidant and cytotoxic effects of circulating heme
Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., & Balla, G. (2002) · Blood · doi:10.1182/blood.v100.3.879 · Cited by 633 · see citing works
Castro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615 · see citing works
Characterization of Heme as Activator of Toll-like Receptor 4
Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., Oliveira, M. F., Oliveira, P. L., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610737200 · Cited by 576 · see citing works
Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., & Akira, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040520 · Cited by 576 · see citing works
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573 · cited 3× · see citing works
“In the Cooperative Study of Sickle Cell Disease, severe acute hemolysis was the only predictor of sudden death due to ACS (15).”
InfluentialHeme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria
Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, Â., Rodrigues, C. D., Gregoire, I. P., Cunha-Rodrigues, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1586 · Cited by 560 · see citing works
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
Rice, T. W., Wheeler, A. P., Bernard, G. R., Vincent, J.-L., Angus, D. C., Aikawa, N., Demeyer, I., Sainati, S., Amlot, N., Cao, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e7c5c9 · Cited by 512 · see citing works
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F. A., Japiassú, A. M., Bonaparte, D., Cavalcante, M. M., Chora, Â., Ferreira, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001118 · Cited by 483 · see citing works
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470 · see citing works
Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467 · see citing works
Mortality in Sickle Cell Disease
Rodgers, G. P., Walker, E. C., & Podgor, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311515 · Cited by 459 · see citing works
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury
Belperio, J. A., Keane, M. P., Burdick, M. D., Londhe, V. A., Xue, Y., Li, K., Phillips, R. J., & Strieter, R. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15849 · Cited by 447 · see citing works
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
Wagener, F. A. D. T. G., Eggert, A. O., Boerman, O. C., Oyen, W. J. G., Verhofstad, A. A. J., Abraham, N. G., Adema, G. J., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Blood · doi:10.1182/blood.v98.6.1802 · Cited by 423 · see citing works
Exchange of Heme among Hemoglobins and between Hemoglobin and Albumin
Bunn, H. F., & Jandl, J. H. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93628-8 · Cited by 415 · see citing works
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
Kaul, D. K., & Hebbel, R. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9225 · Cited by 413 · see citing works
Looney, M. R., Nguyen, J. X., Hu, Y., Ziffle, J. V., Lowell, C. A., & Matthay, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38432 · Cited by 397 · see citing works
Methemoglobin—It's not just blue: A concise review
Umbreit, J. N. (2006) · American Journal of Hematology · doi:10.1002/ajh.20738 · Cited by 380 · see citing works
Müller‐Eberhard, U., Javid, J., Liem, H. H., von Hanstein, A. S., & Hanna, M. (1968) · Blood · doi:10.1182/blood.v32.5.811.811 · Cited by 329 · see citing works
Correction of sickle cell disease by homologous recombination in embryonic stem cells
Wu, L.-C., Sun, C., Ryan, T. M., Pawlik, K. M., Ren, J., & Townes, T. M. (2006) · Blood · doi:10.1182/blood-2006-02-004812 · Cited by 327 · see citing works
Looney, M. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27238 · Cited by 309 · see citing works
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.
Hebbel, R. P., Morgan, W. T., Eaton, J. W., & Hedlund, B. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.237 · Cited by 306 · see citing works
COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1
Burstein, E., Hoberg, J. E., Wilkinson, A. S., Rumble, J. M., Csomos, R. A., Komarck, C. M., Maine, G. N., Wilkinson, J. C., Mayo, M. W., & Duckett, C. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501928200 · Cited by 275 · see citing works
Heme oxygenase-1 affords protection against noncerebral forms of severe malaria
Seixas, E., Gozzelino, R., Chora, Â., Ferreira, A., Silva, G., Larsen, R., Rebelo, S., Penido, C., Smith, N. R., Coutinho, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903419106 · Cited by 275 · see citing works
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
Belcher, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26857 · Cited by 265 · see citing works
Takashima, K., Matsunaga, N., Yoshimatsu, M., Hazeki, K., Kaisho, T., Uekata, M., Hazeki, O., Akira, S., Iizawa, Y., & Ii, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00297.x · Cited by 247 · see citing works
Bernini, J. C., Rogers, Z. R., Sandler, E. S., REISCH, J. S., Quinn, C. T., & Buchanan, G. R. (1998) · Blood · doi:10.1182/blood.v92.9.3082 · Cited by 228 · see citing works
Prevention by polymyxin B of endotoxin lethality in mice
Rifkind, D. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.4.1463-1464.1967 · Cited by 185 · see citing works
Oxidative Stress and Induction of Heme Oxygenase-1 in the Kidney in Sickle Cell Disease
Nath, K. A., Grande, J. P., Haggard, J. J., Croatt, A. J., Katušić, Z. S., Solovey, A. N., & Hebbel, R. P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64037-0 · Cited by 185 · see citing works
ACUTE CHEST SYNDROME IN SICKLE-CELL DISEASE
Davies, S. C., Win, A. A., Luce, P. J., Riordan, J. F., & Brozović, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90193-4 · Cited by 181 · see citing works
Sha, T., Sunamoto, M., Kitazaki, T., Sato, J., Ii, M., & Iizawa, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.027 · Cited by 177 · see citing works
Mechanism of hemolysis induced by ferriprotoporphyrin IX
Chou, A. C., & Fitch, C. D. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110302 · Cited by 168 · see citing works
Hebbel, R. P. (2010) · American Journal of Hematology · doi:10.1002/ajh.21952 · Cited by 167 · see citing works
Wallace, K. L., Marshall, M. A., Ramos, S. I., Lannigan, J. A., Field, J. J., Strieter, R. M., & Linden, J. M. (2009) · Blood · doi:10.1182/blood-2009-02-205492 · Cited by 153 · see citing works
Wallace, K. L., & Linden, J. M. (2010) · Blood · doi:10.1182/blood-2010-06-290643 · Cited by 152 · see citing works
Acute Chest Syndrome in Adults With Sickle Cell Disease
Maître, B., Habibi, A., Roudot‐Thoraval, F., Bachir, D., Belghiti, D., Galactéros, F., & Godeau, B. (2000) · CHEST Journal · doi:10.1378/chest.117.5.1386 · Cited by 131 · see citing works
Hemopexin Prevents Endothelial Damage and Liver Congestion in a Mouse Model of Heme Overload
Vinchi, F., Gastaldi, S., Silengo, L., Altruda, F., & Tolosano, E. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071130 · Cited by 123 · see citing works
Chou, A. C., & Fitch, C. D. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109925 · Cited by 122 · see citing works
Sprinkle, R. H., Cole, T., Smith, S., & Buchanan, G. R. (1986) · PubMed · Cited by 109 · see citing works
Gladwin, M. T., Schechter, A. N., Shelhamer, J. H., & Ognibene, F. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9810094 · Cited by 94 · see citing works
Adisa, O. A., Hu, Y., Ghosh, S., Aryee, D., Osunkwo, I., & Ofori‐Acquah, S. F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12445 · Cited by 88 · see citing works
Self-citationBean, C. J., Boulet, S. L., Ellingsen, D., Pyle, M., Barron‐Casella, E. A., Casella, J. F., Payne, A. B., Driggers, J., Trau, H. A., Yang, G., et al. (2012) · Blood · doi:10.1182/blood-2011-06-361642 · Cited by 83 · see citing works
Self-citationHypoxia-induced acute lung injury in murine models of sickle cell disease
Pritchard, K. A., Ou, J., Ou, Z., Shi, Y., Franciosi, J. P., Signorino, P. R., Kaul, S., Ackland-Berglund, C. E., Witte, K., Holzhauer, S., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00288.2002 · Cited by 79 · see citing works
Franceschi, L. D. (2003) · Blood · doi:10.1182/blood-2002-07-2135 · Cited by 79 · see citing works
Detection of hemin release during hemoglobin S denaturation
Liu, S., Zhai, S., & Palek, J. (1988) · Blood · doi:10.1182/blood.v71.6.1755.1755 · Cited by 72 · see citing works
Comparative Oxidation of Hemoglobins A and S
Sheng, K., Shariff, M., & Hebbel, R. P. (1998) · Blood · doi:10.1182/blood.v91.9.3467 · Cited by 70 · see citing works
Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection
Verhoeven, D. E., Teijaro, J. R., & Färber, D. L. (2009) · Virology · doi:10.1016/j.virol.2009.05.004 · Cited by 65 · see citing works
Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice
Holtzclaw, J. D., Jack, D. L., Aguayo, S. M., Eckman, J. R., Roman, J., & Hsu, L. L.-Y. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-224oc · Cited by 61 · see citing works
Differential effects of chloral hydrate- and ketamine/xylazine-induced anesthesia by the s.c. route
Rodrigues, S. F., Oliveira, M. A., Martins, J. O., Sannomiya, P., Tostes, R. C., Nigro, D., de Carvalho, M. H. C., & Fortes, Z. B. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.05.019 · Cited by 60 · see citing works
Ghosh, S., Tan, F., & Ofori-Acquah, S. F. (2012) · Anemia · doi:10.1155/2012/582018 · Cited by 55 · see citing works
Self-citationSchwarzkopf, T. M., Horn, T., Lang, D., & Klein, J. (2013) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012261 · Cited by 48 · see citing works
Klings, E. S., Christman, B. W., McClung, J. P., Stucchi, A. F., McMahon, L. C., BRAUER, M., & Farber, H. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2101020 · Cited by 46 · see citing works
Sidwell, R. W., Huffman, J. H., Gilbert, J., Moscon, B. J., Pedersen, G., Burger, R., & Warren, R. P. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.473 · Cited by 46 · see citing works
Inhaled Nitric Oxide Improves Survival Rates during Hypoxia in a Sickle Cell (SAD) Mouse Model
Martinez-Ruiz, R., Montero-Huerta, P., Hromi, J., & Head, C. A. (2001) · Anesthesiology · doi:10.1097/00000542-200106000-00028 · Cited by 46 · see citing works
Wochner, R. D., Spilberg, I., Iio, A., Liem, H. H., & Müller‐Eberhard, U. (1974) · New England Journal of Medicine · doi:10.1056/nejm197404112901503 · Cited by 43 · see citing works
McCavit, T. L., Lin, H., Zhang, S., Ahn, C. W., Quinn, C. T., & Flores, G. (2011) · American Journal of Hematology · doi:10.1002/ajh.21977 · Cited by 42 · see citing works
Sepsis study failure highlights need for trial design rethink
Tse, M. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4016 · Cited by 41 · see citing works
Galarneau, G., Coady, S., Garrett, M. E., Jeffries, N. O., Puggal, M. A., Paltoo, D. N., Soldano, K. L., Guasch, A., Ashley‐Koch, A. E., Telen, M. J., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478776 · Cited by 39 · see citing works
Zerez, C., Lachant, N., & Tanaka, K. (1990) · Blood · doi:10.1182/blood.v76.5.1008.1008 · Cited by 34 · see citing works
Acute Chest Syndrome in Adult Afro-Caribbean Patients With Sickle Cell Disease
van Agtmael, M. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420050119011 · Cited by 32 · see citing works
Ghosh, S., Tan, F., Yu, T., Li, Y., Adisa, O. A., Mosunjac, M. I., & Ofori-Acquah, S. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018399 · Cited by 31 · see citing works
Self-citationvan Agtmael, M. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.5.557 · Cited by 31 · see citing works
ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
Zheng, L., Liang, P., Li, J., Huang, X., Liu, S., Zhao, H., Han, K., & Wang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045412 · Cited by 27 · see citing works
Hanson, M. S., Piknova, B., Keszler, Á., Diers, A. R., Wang, X., Gladwin, M. T., Hillery, C. A., & Hogg, N. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08738.x · Cited by 25 · see citing works
The acute chest syndrome of sickle cell disease
Desai, P. C., & Ataga, K. I. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.783570 · Cited by 23 · see citing works
Kaul, D. K., Fabry, M. E., Suzuka, S. M., & Zhang, X. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00296.2012 · Cited by 22 · see citing works
Imanaka, H., Nishimura, M., Miyano, H., Uemura, H., & Yagihara, T. (2001) · Anesthesiology · doi:10.1097/00000542-200110000-00016 · Cited by 10 · see citing works
NA (1823) · The Lancet · doi:10.1016/s0140-6736(01)18847-1 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813 · see citing works
Intravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748 · see citing works
Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695 · see citing works
Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia
Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C., Suvorava, T., Isakson, B. E., Kelm, M., & Cortese-Krott, M. M. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6954 · Cited by 469 · see citing works
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413 · see citing works
Heme on innate immunity and inflammation
Dutra, F. F., & Bozza, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00115 · Cited by 355 · see citing works
Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease
Chen, G., Zhang, D., Fuchs, T. A., Manwani, D., Wagner, D. D., & Frenette, P. S. (2014) · Blood · doi:10.1182/blood-2013-10-529982 · Cited by 354 · see citing works
Hemolysis-induced lethality involves inflammasome activation by heme
Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B., Golenbock, D. T., Zamboni, D. S., & Bozza, M. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405023111 · Cited by 353 · see citing works
Inflammation in sickle cell disease
Conran, N., & Belcher, J. D. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189012 · Cited by 305 · see citing works
Vinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., & Muckenthaler, M. U. (2016) · Blood · doi:10.1182/blood-2015-08-663245 · Cited by 269 · see citing works
Schaer, D. J., Vinchi, F., Ingoglia, G., Tolosano, E., & Buehler, P. W. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00415 · Cited by 275 · see citing works
Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders
Smith, A., & McCulloh, R. J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00187 · Cited by 258 · see citing works
Camus, S. M., Moraes, J. A., Bonnin, P., Abbyad, P., Jeune, S. L., Lionnet, F., Loufrani, L., Grimaud, L., Lambry, J., Charue, D., et al. (2015) · Blood · doi:10.1182/blood-2014-07-589283 · Cited by 261 · see citing works
Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs
Bozza, M. T., & Jeney, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01323 · Cited by 205 · see citing works
Heme dynamics and trafficking factors revealed by genetically encoded fluorescent heme sensors
Hanna, D. A., Harvey, R. M., Martinez-Guzman, O., Yuan, X., Chandrasekharan, B. P., Raju, G., Outten, F. W., Hamza, I., & Reddi, A. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523802113 · Cited by 197 · see citing works
The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
Nader, É., Romana, M., & Connes, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00454 · Cited by 194 · see citing works
Qiu, Y., Ahn, B., Sakurai, Y., Hansen, C. E., Tran, R., Mimche, P. N., Mannino, R. G., Ciciliano, J. C., Lamb, T. J., Joiner, C. H., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0224-z · Cited by 188 · see citing works
Self-citationChaturvedi, S., & DeBaun, M. R. (2015) · American Journal of Hematology · doi:10.1002/ajh.24235 · Cited by 187 · see citing works
Therapeutic strategies for sickle cell disease: towards a multi-agent approach
Telen, M. J., Malik, P., & Vercellotti, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0003-2 · Cited by 184 · see citing works
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
Gordeuk, V. R., Castro, O. L., & Machado, R. F. (2016) · Blood · doi:10.1182/blood-2015-08-618561 · Cited by 178 · see citing works
Deuel, J., Schaer, C. A., Boretti, F. S., Opitz, L., García‐Rubio, I., Baek, J. H., Spahn, D. R., Buehler, P. W., & Schaer, D. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.392 · Cited by 173 · see citing works
Atherogenesis and iron: from epidemiology to cellular level
Vinchi, F., Muckenthaler, M. U., da Silva, M. C., Balla, G. J., Balla, J., & Jeney, V. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00094 · Cited by 173 · see citing works
Acute Chest Syndrome in Children with Sickle Cell Disease
Jain, S., Bakshi, N., & Krishnamurti, L. (2017) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2017.0814 · Cited by 170 · see citing works
Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics
Vallelian, F., Buehler, P. W., & Schaer, D. J. (2022) · Blood · doi:10.1182/blood.2022015596 · Cited by 169 · see citing works
Novelli, E. M., & Gladwin, M. T. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.016 · Cited by 166 · see citing works
Cardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164 · see citing works
Red cell DAMPs and inflammation
Mendonça, R., Silveira, A. A. A., & Conran, N. (2016) · Inflammation Research · doi:10.1007/s00011-016-0955-9 · Cited by 157 · see citing works
Red alert: labile heme is an alarmin
Soares, M. P., & Bozza, M. T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.006 · Cited by 148 · see citing works
Heme: Modulator of Plasma Systems in Hemolytic Diseases
Roumenina, L. T., Rayes, J., Lacroix‐Desmazes, S., & Dimitrov, J. D. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.004 · Cited by 149 · see citing works
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Bennewitz, M. F., Jimenez, M. A., Vats, R., Tutuncuoglu, E., Jonassaint, J., Kato, G. J., Gladwin, M. T., & Sundd, P. (2017) · JCI Insight · doi:10.1172/jci.insight.89761 · Cited by 139 · see citing works
Vasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 133 · see citing works
The impact of xanthine oxidase (XO) on hemolytic diseases
Schmidt, H. M., Kelley, E. E., & Straub, A. C. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101072 · Cited by 131 · see citing works
Heme as a Target for Therapeutic Interventions
Immenschuh, S., Vijayan, V., Janciauskiene, S. M., & Gueler, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00146 · Cited by 130 · see citing works
Belcher, J. D., Chen, C., Nguyen, J., Zhang, P., Abdulla, F. A., Nguyen, P., Killeen, T. F., Xu, P. C., O'Sullivan, G., Nath, K. A., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6571 · Cited by 116 · see citing works
Belcher, J. D., Chen, C., Nguyen, J., Abdulla, F. A., Zhang, P., Nguyen, H. V., Nguyen, P., Killeen, T. F., Miescher, S., Brinkman, N. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196455 · Cited by 115 · see citing works
The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease
Gbotosho, O. T., Kapetanaki, M. G., & Kato, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.561917 · Cited by 117 · see citing works
Erythroid DAMPs drive inflammation in SCD
Gladwin, M. T., & Ofori-Acquah, S. F. (2014) · Blood · doi:10.1182/blood-2014-03-563874 · Cited by 113 · see citing works
Self-citationRole of Heme in Cardiovascular Physiology and Disease
Sawicki, K. T., Chang, H., & Ardehali, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001138 · Cited by 111 · see citing works
Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease
van Beers, E. J., Yang, Y., Raghavachari, N., Tian, X., Allen, D. T., Nichols, J. S., Mendelsohn, L. G., Nekhai, S. A., Gordeuk, V. R., Taylor, J. G., et al. (2014) · Circulation Research · doi:10.1161/circresaha.116.304577 · Cited by 100 · see citing works
The Development and Consequences of Red Blood Cell Alloimmunization
Arthur, C. M., & Stowell, S. R. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-110411 · Cited by 97 · see citing works
Cell-free hemoglobin: a novel mediator of acute lung injury
Shaver, C. M., Upchurch, C. P., Janz, D. R., Grove, B. S., Putz, N. D., Wickersham, N. E., Dikalov, S., Ware, L. B., & Bastarache, J. A. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00155.2015 · Cited by 95 · see citing works
Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit
Frimat, M., Boudhabhay, I., & Roumenina, L. T. (2019) · Toxins · doi:10.3390/toxins11110660 · Cited by 96 · see citing works
Vats, R., Brzóska, T., Bennewitz, M. F., Jimenez, M. A., Pradhan‐Sundd, T., Tütüncüoğlu, E., Jonassaint, J., Gutierrez, E., Watkins, S. C., Shiva, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1370oc · Cited by 97 · see citing works
Wang, Q., & Zennadi, R. (2021) · Antioxidants · doi:10.3390/antiox10101608 · Cited by 101 · see citing works
Protein aggregation as a cellular response to oxidative stress induced by heme and iron
Vasconcellos, L. R., Dutra, F. F., Siqueira, M. S., Paula-Neto, H. A., Dahan, J., Kiarely, E., Carneiro, L., Bozza, M., & Travassos, L. (2016) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1608928113 · Cited by 86 · see citing works
Haptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity
Buehler, P. W., Humar, R., & Schaer, D. J. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.02.004 · Cited by 89 · see citing works
Heme Catabolic Pathway in Inflammation and Immune Disorders
Wu, B., Wu, Y., & Tang, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00825 · Cited by 86 · see citing works
Excess of heme induces tissue factor-dependent activation of coagulation in mice
Sparkenbaugh, E., Chantrathammachart, P., Wang, S., Jonas, W., Kirchhofer, D., Gailani, D., Gruber, A., Kasthuri, R. S., Key, N. S., Mackman, N., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.114728 · Cited by 85 · see citing works
Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes
Pfefferlé, M., Ingoglia, G., Schaer, C. A., Yalamanoglu, A., Buzzi, R. M., Dubach, I. L., Tan, G., López-Cano, E. Y., Schulthess-Lutz, N., Hansen, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137282 · Cited by 75 · see citing works
Characterization of plasma labile heme in hemolytic conditions
Gouveia, Z., Carlos, A. R., Yuan, X., Aires‐da‐Silva, F., Stocker, R., Maghzal, G. J., Leal, S. S., Gomes, C. M., Todorovic, S., Iranzo, O., et al. (2017) · The FEBS Journal · doi:10.1111/febs.14192 · Cited by 70 · see citing works
Chonat, S., Quarmyne, M., Bennett, C. M., Dean, C. L., Joiner, C. H., Fasano, R. M., & Stowell, S. R. (2018) · Haematologica · doi:10.3324/haematol.2018.194670 · Cited by 73 · see citing works
Innate immune cells, major protagonists of sickle cell disease pathophysiology
Allali, S., Maciel, T. T., Hermine, O., & de Montalembert, M. (2020) · Haematologica · doi:10.3324/haematol.2019.229989 · Cited by 72 · see citing works
Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation
Dimitrov, J. D., Roumenina, L. T., Perrella, G., & Rayes, J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318780 · Cited by 72 · see citing works
Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress
Vallelian, F., Deuel, J., Opitz, L., Schaer, C. A., Puglia, M., Lönn, M. E., Engelsberger, W. R., Schauer, S., Karnaukhova, E., Spahn, D. R., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.154 · Cited by 71 · see citing works
Jana, S., Strader, M. B., Meng, F., Hicks, W. A., Kassa, T., Tarandovskiy, I. D., Paoli, S. D., Šimák, J., Heaven, M. R., Belcher, J. D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120451 · Cited by 70 · see citing works
Haematological determinants of cardiac involvement in adults with sickle cell disease
Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv555 · Cited by 65 · see citing works
Vats, R., Kaminski, T. W., Brzóska, T., Leech, J. A., Tütüncüoğlu, E., Katoch, O., Jonassaint, J., Tejero, J., Novelli, E. M., Pradhan‐Sundd, T., et al. (2022) · Blood · doi:10.1182/blood.2021014552 · Cited by 66 · see citing works
Oh, J., Hamm, J. D., Xu, X., Genschmer, K. R., Zhong, M., Lebensburger, J. D., Marques, M. B., Kerby, J. D., Pittet, J., Gaggar, A., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.003 · Cited by 66 · see citing works
Revisiting the putative role of heme as a trigger of inflammation
Vallelian, F., Schaer, C. A., Deuel, J., Ingoglia, G., Humar, R., Buehler, P. W., & Schaer, D. J. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.392 · Cited by 62 · see citing works
Critical role of C5a in sickle cell disease
Vercellotti, G. M., Dalmasso, A. P., Schaid, T. R., Nguyen, J., Chen, C., Ericson, M. E., Abdulla, F. A., Killeen, T. F., Lindorfer, M. A., Taylor, R. P., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25384 · Cited by 64 · see citing works
Oxidative pathways in the sickle cell and beyond
Alayash, A. I. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.05.009 · Cited by 63 · see citing works
Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation
Xu, H., Wandersee, N. J., Guo, Y. H., Jones, D. W., Holzhauer, S., Hanson, M. S., Machogu, E. M., Brousseau, D. C., Hogg, N., Densmore, J. C., et al. (2014) · Blood · doi:10.1182/blood-2014-04-560813 · Cited by 59 · see citing works
Chaturvedi, S., Ghafuri, D. L., Glassberg, J., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2016) · American Journal of Hematology · doi:10.1002/ajh.24539 · Cited by 60 · see citing works
Allali, S., Rignault‐Bricard, R., de Montalembert, M., Taylor, M., Bouceba, T., Hermine, O., & Maciel, T. T. (2022) · Blood · doi:10.1182/blood.2021014894 · Cited by 61 · see citing works
Chaturvedi, S., Ghafuri, D. L., Jordan, N., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2018) · American Journal of Hematology · doi:10.1002/ajh.25202 · Cited by 59 · see citing works
Arumugam, P. I., Mullins, E. S., Shanmukhappa, S. K., Monia, B. P., Loberg, A., Shaw, M. A., Rizvi, T. A., Wansapura, J. P., Degen, J. L., & Malik, P. (2015) · Blood · doi:10.1182/blood-2015-01-625707 · Cited by 59 · see citing works
Vinchi, F., Sparla, R., Passos, S., Sharma, R., Vance, S. Z., Zreid, H., Juaidi, H., Manwani, D. G., Yazdanbakhsh, K., Nandi, V., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17361 · Cited by 57 · see citing works
Hemopexin in severe inflammation and infection: mouse models and human diseases
Lin, T., Maita, D., Thundivalappil, S. R., Riley, F. E., Hambsch, J., Marter, L. J. V., Christou, H. A., Berra, L. M., Fagan, S. P., Christiani, D. C., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0885-x · Cited by 56 · see citing works
Kassa, T., Jana, S., Strader, M. B., Meng, F., Jia, Y., Wilson, M. T., & Alayash, A. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651257 · Cited by 57 · see citing works
Wagener, B. M., Hu, P. J., Oh, J., Evans, C. A., Richter, J. R., Honavar, J., Brandon, A. P., Creighton, J. R., Stephens, S. W., Morgan, C. J., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002522 · Cited by 56 · see citing works
Merle, N. S., Grünenwald, A., Figueres, L., Chauvet, S., Daugan, M. V., Knockaert, S., Robe-Rybkine, T., Noé, R., May, O., Frimat, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00179 · Cited by 55 · see citing works
Heme‐related molecules induce rapid production of neutrophil extracellular traps
Kono, M., Saigo, K., Takagi, Y., Takahashi, T., Kawauchi, S., Wada, A., Hashimoto, M., Minami, Y., Imoto, S., Takenokuchi, M., et al. (2014) · Transfusion · doi:10.1111/trf.12700 · Cited by 53 · see citing works
Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death
Singla, S., Sysol, J. R., Dille, B., Jones, N., Chen, J., & Machado, R. F. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0287oc · Cited by 53 · see citing works
Blood rheological abnormalities in sickle cell anemia
Connes, P., Renoux, C., Romana, M., Abkarian, M., Joly, P., Martin, C., Hardy‐Dessources, M., & Ballas, S. K. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189005 · Cited by 52 · see citing works
Stapley, R. D., Rodriguez, C. A., Oh, J., Honavar, J., Brandon, A. P., Wagener, B. M., Marques, M. B., Weinberg, J. A., Kerby, J. D., Pittet, J., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.025 · Cited by 51 · see citing works
HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease
Liu, Y., Jing, F., Yi, W., Mendelson, A., Shi, P., Walsh, R., Friedman, D. F., Minniti, C., Manwani, D., Chou, S. T., et al. (2018) · Blood · doi:10.1182/blood-2017-12-819870 · Cited by 51 · see citing works
Comparative Analysis of Pain Behaviours in Humanized Mouse Models of Sickle Cell Anemia
Lei, J., Benson, B. A., Tran, H., Ofori-Acquah, S. F., & Gupta, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160608 · Cited by 52 · see citing works
Self-citationVercellotti, G. M., Zhang, P., Nguyen, J., Abdulla, F. A., Chen, C., Nguyen, P., Nowotny, C., Steer, C. J., Smith, A., & Belcher, J. D. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00063 · Cited by 51 · see citing works
Lei, J., Paul, J. A., Wang, Y., Gupta, M., Vang, D., Thompson, S. T., Jha, R., Nguyen, J., Valverde, Y., Lamarre, Y., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7913 · Cited by 51 · see citing works
Hounkpe, B. W., Fiusa, M. M. L., Colella, M. P., da Costa, L. N. G., Benatti, R. O., Saad, S. T. O., Costa, F. F., Santos, M. N. N., & Paula, E. V. D. (2015) · Scientific Reports · doi:10.1038/srep17822 · Cited by 49 · see citing works
Krishnamoorthy, S., Pace, B. S., Gupta, D., Sturtevant, S., Li, Y., Makala, L., Brittain, J. E., Moore, N., Vieira, B. F., Thullen, T. D., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96409 · Cited by 48 · see citing works
Noncanonical Roles of Caspase-4 and Caspase-5 in Heme-Driven IL-1β Release and Cell Death
Bolívar, B. E., Brown-Suedel, A. N., Rohrman, B. A., Charendoff, C. I., Yazdani, V., Belcher, J. D., Vercellotti, G. M., Flanagan, J. M., & Bouchier‐Hayes, L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000226 · Cited by 47 · see citing works
Morphine for the Treatment of Pain in Sickle Cell Disease
Gupta, M., Msambichaka, L. A., Ballas, S. K., & Gupta, K. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/540154 · Cited by 46 · see citing works
Wang, X., Mendelsohn, L. G., Rogers, H. M., Leitman, S. F., Raghavachari, N., Yang, Y., Yau, Y. Y., Tallack, M. R., Perkins, A. C., Taylor, J. G., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539718 · Cited by 45 · see citing works
Inflammatory targets of therapy in sickle cell disease
Owusu-Ansah, A. T., Ihunnah, C. A., Walker, A. L., & Ofori-Acquah, S. F. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.001 · Cited by 45 · see citing works
Self-citationAltered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization
Godefroy, E., Liu, Y., Shi, P. A., Mitchell, W. B., Cohen, D., Chou, S. T., Manwani, D. G., & Yazdanbakhsh, K. (2016) · Haematologica · doi:10.3324/haematol.2016.147181 · Cited by 44 · see citing works
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress
Ingoglia, G., Sag, C. M., Rex, N., Franceschi, L. D., Vinchi, F., Cimino, J., Petrillo, S., Wagner, S., Kreitmeier, K., Silengo, L., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.003 · Cited by 43 · see citing works
Role of TLR4 signaling in the nephrotoxicity of heme and heme proteins
Nath, K. A., Belcher, J. D., Nath, M. C., Grande, J. P., Croatt, A. J., Ackerman, A. W., Katušić, Z. S., & Vercellotti, G. M. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00432.2017 · Cited by 44 · see citing works
Hypercoagulable state in sickle cell disease
Faës, C., Sparkenbaugh, E., & Pawliński, R. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189013 · Cited by 43 · see citing works
Hemopexin deficiency promotes acute kidney injury in sickle cell disease
Ofori-Acquah, S. F., Hazra, R., Orikogbo, O., Crosby, D. E., Flage, B., Ackah, E. B., Lenhart, D., Tan, R. J., Vitturi, D. A., Paintsil, V., et al. (2020) · Blood · doi:10.1182/blood.2019002653 · Cited by 44 · see citing works
Self-citationSickle cell disease: progress towards combination drug therapy
Pace, B. S., Starlard‐Davenport, A., & Kutlar, A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17312 · Cited by 43 · see citing works
Yin, T., He, S., Liu, X., Jiang, W., Ye, T., Lin, Z., Sang, Y., Su, C., Wan, Y., Shen, G., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400643 · Cited by 42 · see citing works
Cell-penetrating peptides selectively targeting SMAD3 inhibit profibrotic TGF-β signaling
Kang, J. H., Jung, M.-Y., Yin, X., Andrianifahanana, M., Hernandez, D. M., & Leof, E. B. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88696 · Cited by 42 · see citing works
Identification of a Heme Activation Site on the MD-2/TLR4 Complex
Belcher, J. D., Zhang, P., Nguyen, J., Kiser, Z. M., Nath, K. A., Hu, J., Trent, J. O., & Vercellotti, G. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01370 · Cited by 41 · see citing works
Vercellotti, G. M., Khan, F. B., Nguyen, J., Chen, C., Bruzzone, C. M., Bechtel, H., Brown, G., Nath, K. A., Steer, C. J., Hebbel, R. P., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00079 · Cited by 38 · see citing works
Platelet activation and ferroptosis mediated NETosis drives heme induced pulmonary thrombosis
NaveenKumar, S. K., Hemshekhar, M., SharathBabu, B. N., Kemparaju, K., Mugesh, G., & Girish, K. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166688 · Cited by 37 · see citing works
Bennewitz, M. F., Watkins, S. C., & Sundd, P. (2014) · IntraVital · doi:10.4161/intv.29748 · Cited by 37 · see citing works
Sarode, R., Ballas, S. K., Garcia, A., Kim, H. C., King, K. E., Sachais, B. S., & Williams, L. A. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21511 · Cited by 37 · see citing works
Potoka, K. P., Wood, K. C., Baust, J., Bueno, M., Hahn, S. A., Vanderpool, R. R., Bachman, T. N., Mallampalli, G. M., Osei-Hwedieh, D. O., Schrott, V. M., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0292oc · Cited by 35 · see citing works
Vascularized Microfluidics and the Blood–Endothelium Interface
Hesh, C. A., Qiu, Y., & Lam, W. A. (2019) · Micromachines · doi:10.3390/mi11010018 · Cited by 36 · see citing works
- Authors
- Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F.
- Affiliations
- Emory University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2013-10-01
- Volume
- 123
- Issue
- 11
- Pages
- 4809-4820
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3809772
- OpenAlex
- W2100360129
- Cited by
- 282
- References
- 72
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 14 · 2023: 23 · 2022: 17 · 2021: 29 · 2020: 24 · 2019: 19 · 2018: 25 · 2017: 19 · 2016: 37 · 2015: 23 · 2014: 18 · 2013: 2
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Emory University
- National Heart, Lung, and Blood Institute (R01HL106192, K02HL088026, U01HL117721)
- Topics
- Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- acute chest syndrome, sickle cell disease, hemolysis, TLR4, hemopexin, acute lung injury, respiratory failure, TLR4 inhibition, lung injury pathogenesis, bone marrow chimeras
- MeSH terms
- Anemia, Sickle Cell, Animals, Disease Models, Animal, Extracellular Space, Hemin, Hemoglobin, Sickle, Hemolysis, Hemopexin, Humans, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Recombinant Proteins, Sickle Cell Trait, Sulfonamides, Mice, Knockout, Toll-Like Receptor 4, Mice, Acute Chest Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review